Literature DB >> 16091742

c-Abl regulates early growth response protein (EGR1) in response to oxidative stress.

Jeremy R Stuart1, Hidehiko Kawai, Kelvin K C Tsai, Eric Y Chuang, Zhi-Min Yuan.   

Abstract

c-Abl is a tyrosine kinase that can act as a regulator of cell growth and apoptosis in response to stress. Using cell lines expressing c-Abl in an inducible manner, we identified genes whose expression was regulated by c-Abl kinase activity. Microarray analysis indicated that Early Growth Response-1 (EGR1) gene expression is induced by c-Abl kinase activity, which was confirmed at the message and protein levels. Promoter mapping experiments revealed that c-Abl utilizes three distal serum response elements (SREs) in the EGR1 promoter, which are transactivated by mitogen/extracellular receptor kinase (MEK/ERK) signaling. PD 95089, a specific inhibitor of MEK/ERK signaling, attenuated c-Abl-mediated upregulation of EGR1 expression in a dose-dependent manner. Similar results were obtained by using a dominant-negative mutant of mitogen/extracellular kinase. Significantly, hydrogen peroxide-induced EGR1 expression appears to be mediated by c-Abl, as cells expressing dominant negative c-Abl, and c-Abl-/- murine embryonic fibroblasts, are completely defective in hydrogen peroxide-induced EGR1 expression. In addition, c-Abl-induced apoptosis is partially mitigated by EGR1 activity, as cells devoid of EGR1 expression undergo reduced rates of c-Abl-induced apoptosis. Together, these results indicate that c-Abl promotes the induction of EGR1 through the MEK/ERK pathway in regulating apoptotic response to oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16091742     DOI: 10.1038/sj.onc.1208953

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  Involvement of c-Abl Kinase in Microglial Activation of NLRP3 Inflammasome and Impairment in Autolysosomal System.

Authors:  Vivek Lawana; Neeraj Singh; Souvarish Sarkar; Adhithiya Charli; Huajun Jin; Vellareddy Anantharam; Anumantha G Kanthasamy; Arthi Kanthasamy
Journal:  J Neuroimmune Pharmacol       Date:  2017-05-02       Impact factor: 4.147

2.  Regulatory mechanism of downregulation of SOD1 expression on cardiomyocyte function.

Authors:  Na Dong; Wei-Ying Liu
Journal:  Sleep Breath       Date:  2022-03-21       Impact factor: 2.816

3.  A molecular signature of proteinuria in glomerulonephritis.

Authors:  Heather N Reich; David Tritchler; Daniel C Cattran; Andrew M Herzenberg; Felix Eichinger; Anissa Boucherot; Anna Henger; Celine C Berthier; Viji Nair; Clemens D Cohen; James W Scholey; Matthias Kretzler
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

4.  A phosphotyrosine switch determines the antitumor activity of ERβ.

Authors:  Bin Yuan; Long Cheng; Huai-Chin Chiang; Xiaojie Xu; Yongjian Han; Hang Su; Lingxue Wang; Bo Zhang; Jing Lin; Xiaobing Li; Xiangyang Xie; Tao Wang; Rajeshwar R Tekmal; Tyler J Curiel; Zhi-Min Yuan; Richard Elledge; Yanfen Hu; Qinong Ye; Rong Li
Journal:  J Clin Invest       Date:  2014-06-24       Impact factor: 14.808

5.  Low-dose radiation-induced senescent stromal fibroblasts render nearby breast cancer cells radioresistant.

Authors:  Kelvin K C Tsai; Jeremy Stuart; Yao-Yu Eric Chuang; John B Little; Zhi-Min Yuan
Journal:  Radiat Res       Date:  2009-09       Impact factor: 2.841

6.  Oxidative stress promotes transcriptional up-regulation of Fyn in BCR-ABL1-expressing cells.

Authors:  Yin Gao; Adrienne Howard; Kechen Ban; Joya Chandra
Journal:  J Biol Chem       Date:  2009-01-08       Impact factor: 5.157

7.  Smad-independent transforming growth factor-beta regulation of early growth response-1 and sustained expression in fibrosis: implications for scleroderma.

Authors:  Swati Bhattacharyya; Shu-Jen Chen; Minghua Wu; Matthew Warner-Blankenship; Hongyan Ning; Gabriella Lakos; Yasuji Mori; Eric Chang; Chihiro Nihijima; Kazuhiro Takehara; Carol Feghali-Bostwick; John Varga
Journal:  Am J Pathol       Date:  2008-09-04       Impact factor: 4.307

8.  A non-Smad mechanism of fibroblast activation by transforming growth factor-beta via c-Abl and Egr-1: selective modulation by imatinib mesylate.

Authors:  S Bhattacharyya; W Ishida; M Wu; M Wilkes; Y Mori; M Hinchcliff; E Leof; J Varga
Journal:  Oncogene       Date:  2009-01-19       Impact factor: 9.867

9.  The cinnamon-derived Michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growth.

Authors:  Christopher M Cabello; Warner B Bair; Sarah D Lamore; Stephanie Ley; Alexandra S Bause; Sara Azimian; Georg T Wondrak
Journal:  Free Radic Biol Med       Date:  2008-11-01       Impact factor: 7.376

10.  The chemokine interleukin-8 and the surface activation protein CD69 are markers for Bcr-Abl activity in chronic myeloid leukemia.

Authors:  Oliver Hantschel; Agnes Gstoettenbauer; Jacques Colinge; Ines Kaupe; Martin Bilban; Thomas R Burkard; Peter Valent; Giulio Superti-Furga
Journal:  Mol Oncol       Date:  2008-07-23       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.